FDA: FDA Guidance for Industry: Electronic Source Data in Clinical Investigations
10.07.2014
This new FDA Guidance defines the FDA\'s expectations for sponsors, CROs, investigators and other persons involved in the capture, review and retention of electronic source data generated in the context of FDA-regulated clinical trials.
SciencePharma
